Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biosimilars
Pharma
China biotech deals, Shionogi's ALS buy—Fierce Pharma Asia
AbbVie, AstraZeneca, Servier, Sanofi and Ipsen inked licensing deals with Chinese biotechs. Shionogi bought Tanabe Pharma's Radicava business.
Angus Liu
Jan 9, 2026 3:00am
Partners Alvotech, Teva eye 2026 Eylea biosimilar launch
Dec 19, 2025 10:40am
FDA finalizes guidance on biosimilar promotional materials
Dec 10, 2025 12:45pm
Biocon buys out Viatris and others from biosimilar subsidiary
Dec 9, 2025 1:56pm
Mark Cuban says FDA should lower fees for generic drug approvals
Dec 5, 2025 4:15pm
FDA’s plan to boost biosims could stall at the patent office
Nov 17, 2025 9:04am